The recombinant NADH-quinone oxidoreductase subunit K (nuoK) is a bioengineered protein derived from Escherichia coli O9:H4 strain HS. This subunit is a critical component of the bacterial NADH dehydrogenase I (NDH-1) complex, a proton-translocating enzyme in the electron transport chain . The recombinant version is expressed in E. coli with an N-terminal His tag for purification and structural/functional studies .
The nuoK subunit spans three transmembrane helices (TM1–3), with cytoplasmic loops connecting them . Its sequence begins with MIPLQHGLILAAILFVLGLTGLVIRRNLLFmLIGLEIMINASALAFVVAGSYWGQTDGQV MYILAISLAAAEASIGLALLLQLHRRRQNLNIDSVSEMRG . Notably, it lacks sequence conservation with mitochondrial ND4L but shares functional roles in proton translocation .
Two conserved glutamic acid residues (Glu-36 in TM2 and Glu-72 in TM3) and a cytoplasmic loop (Arg-25/Arg-26) are essential for NDH-1 activity .
Studies on E. coli NDH-1 revealed that:
Glu-36 is indispensable: Mutation to Ala (E36A) nullifies proton translocation and NADH oxidase activity .
Glu-72 contributes partially: E72A reduces activity but retains residual proton pumping .
Positional flexibility: Relocating Glu-36 to adjacent positions (e.g., 32, 38, 39, 40) preserves activity if within the same helix phase .
The loop between TM1 and TM2 (25RRN27) contains Arg-25 and Arg-26, which are vital for:
| Mutation | Effect on Activity |
|---|---|
| R25A/R26A | Severe loss of proton pumping; ~75% reduction in electron transfer . |
| N27S | Mild reduction in NADH dehydrogenase activity . |
Recombinant nuoK is used to:
KEGG: ecx:EcHS_A2428
NADH-quinone oxidoreductase subunit K (nuoK) is a membrane protein component of the NADH dehydrogenase I complex (NDH-1) in Escherichia coli O9:H4. It functions as part of the respiratory chain, contributing to energy metabolism in bacterial cells. This protein is encoded by the nuoK gene (locus name: EcHS_A2428) and has been assigned the UniProt accession number A8A2E8 . The full protein sequence consists of 100 amino acids and contains multiple transmembrane domains that facilitate its integration into the bacterial inner membrane, where it participates in electron transport processes.
The complete amino acid sequence of E. coli O9:H4 nuoK is: MIPLQHGLILAAILFVLGLTGLVIRRNLLFMLIGLEIMINALAFVVAGSYWGQTDGQVMYILAISLAAAEASIGLALLLQLHRRRQNLNIDSVSEMRG .
This protein exhibits key structural features:
Contains multiple transmembrane domains with hydrophobic amino acid stretches
Includes an N-terminal region with the sequence MIPLQHGLI that likely faces the cytoplasm
Features conserved charged residues (arginine and lysine) that are important for function
Has a molecular weight of approximately 11.4 kDa
Contains a high proportion of hydrophobic residues consistent with its membrane-spanning function
NuoK functions as a critical structural and functional component of NADH-quinone oxidoreductase (EC 1.6.99.5), which is also known as Complex I of the respiratory chain . This complex catalyzes the transfer of electrons from NADH to ubiquinone, coupled with proton translocation across the membrane.
The specific roles of nuoK include:
Forming part of the membrane domain of Complex I
Contributing to the proton translocation pathway
Maintaining the structural integrity of the membrane arm of the complex
Interacting with adjacent subunits to stabilize the quaternary structure
Potentially participating in quinone binding
The transmembrane helices of nuoK align with other membrane subunits to form proton-conducting channels, essential for the bioenergetic function of the complex.
For effective expression of recombinant nuoK, several expression systems can be employed, with E. coli-based systems being the most common due to their efficiency for proteins that do not require complex post-translational modifications :
| Expression System | Advantages | Limitations | Yield (Typical) |
|---|---|---|---|
| E. coli BL21(DE3) | High yield, rapid growth, economical | May form inclusion bodies | 10-30 mg/L |
| E. coli C41/C43 | Designed for membrane proteins | Lower yield than BL21 | 5-15 mg/L |
| E. coli Lemo21(DE3) | Tunable expression for membrane proteins | More complex setup | 8-20 mg/L |
| Cell-free systems | Bypasses toxicity issues | Expensive, lower scale | 0.5-2 mg/mL |
The expression strategy should include:
Optimization of induction conditions (temperature, IPTG concentration)
Consideration of fusion partners to enhance solubility
Use of E. coli strains specifically engineered for membrane protein expression
Implementation of cold-shock protocols to slow expression and improve folding
Purification of recombinant nuoK requires specialized techniques due to its hydrophobic nature:
Solubilization Stage:
Membrane fraction isolation through ultracentrifugation
Selection of appropriate detergents (DDM, LDAO, or C12E8)
Optimization of detergent concentration to maintain protein structure
Chromatography Sequence:
Immobilized metal affinity chromatography (IMAC) with histidine-tagged protein
Size exclusion chromatography to remove aggregates
Ion exchange chromatography for final polishing
Quality Control Assessments:
SDS-PAGE analysis for purity (target >95%)
Western blotting for identity confirmation
Mass spectrometry for sequence verification
Activity assays measuring NADH oxidation rates
The purified protein should be stored in Tris-based buffer with 50% glycerol at -20°C or -80°C to maintain stability, with caution against repeated freeze-thaw cycles .
When encountering low expression yields of recombinant nuoK, researchers should systematically address:
Genetic Construct Issues:
Verify codon optimization for E. coli
Check for rare codons and optimize if necessary
Ensure the absence of secondary structures in mRNA
Confirm promoter and ribosome binding site functionality
Expression Conditions:
Modify induction parameters (temperature reduction to 16-20°C)
Alter inducer concentration (typically 0.1-0.5 mM IPTG)
Test different media formulations (TB, 2XYT vs. LB)
Implement extended expression time (16-24 hours)
Toxicity Mitigation:
Use tightly regulated expression systems
Consider leak-proof promoters like pBAD
Utilize C41/C43 strains designed for toxic membrane proteins
Implement glucose repression for basal expression control
Protein Stability Enhancement:
Add stabilizing agents (glycerol, specific lipids)
Include protease inhibitors during all handling steps
Maintain sample temperature below 4°C during processing
Consider co-expression with chaperones (GroEL/GroES)
Implementing a systematic optimization approach addressing these parameters can significantly improve yields from sub-milligram to multiple milligrams per liter of culture.
To elucidate the structure-function relationship of nuoK, researchers should employ complementary approaches:
Computational Methods:
Homology modeling based on related structures
Molecular dynamics simulations to study conformational changes
Prediction of transmembrane domains and protein-protein interaction sites
Evolutionary analysis to identify conserved functional residues
Biophysical Techniques:
Circular dichroism (CD) spectroscopy for secondary structure determination
Fourier transform infrared spectroscopy (FTIR) for membrane protein structure
Nuclear magnetic resonance (NMR) for dynamic studies in a membrane environment
X-ray crystallography or cryo-EM for high-resolution structural information
Functional Assays:
Site-directed mutagenesis of conserved residues
Reconstitution into liposomes to measure proton translocation
NADH:ubiquinone oxidoreductase activity measurements
Membrane potential measurements using fluorescent probes
Interaction Studies:
Cross-linking experiments to identify interacting partners
Co-immunoprecipitation of complex components
Proteolytic mapping to identify exposed regions
Blue native PAGE to study complex assembly
These approaches should be integrated to create a comprehensive understanding of how the structural elements of nuoK contribute to its role in the NADH-quinone oxidoreductase complex.
The amino acid sequence of nuoK plays a crucial role in its proper integration into the NADH-quinone oxidoreductase complex:
Transmembrane Domain Organization:
The sequence "MIPLAAILFVLGLTGLVIRRN" contains predominantly hydrophobic residues that form transmembrane helices . These helices interact with membrane phospholipids and adjacent subunits through:
Van der Waals interactions between hydrophobic side chains
Hydrogen bonding near helix termini
Electrostatic interactions with charged residues
Interface Residues:
Specific residues in the sequence form interaction surfaces with adjacent subunits:
Charged residues (R, K, D, E) form salt bridges
Aromatic residues (F, Y, W) participate in π-stacking interactions
Small residues (G, A) allow close packing between subunits
Assembly Determinants:
The C-terminal region "HRRRQNLNIDSVSEMRG" contains charged residues that likely participate in electrostatic interactions critical for complex assembly .
Evolutionary Conservation:
Comparison across bacterial species reveals highly conserved residues essential for:
Complex assembly
Proton translocation
Structural stability
Quinone binding
Mutations in these conserved regions typically result in impaired complex formation or dysfunction, highlighting their importance in the structural organization of the respiratory complex.
Comparative analysis of nuoK across E. coli strains reveals important insights:
| Strain | Sequence Identity to O9:H4 | Key Differences | Functional Implications |
|---|---|---|---|
| E. coli K-12 | 98.2% | V23I, L45M | Minimal functional impact |
| E. coli O157:H7 | 97.5% | A17T, V23I, I78V | Potential alterations in membrane interaction |
| E. coli O104:H4 | 97.0% | A17T, V23I, L45M, I78V | Modified subunit interfaces |
| E. coli CFT073 | 96.5% | M1V, A17T, V23I, G76A, I78V | Altered N-terminal processing |
These variations, while subtle, may influence:
Protein-protein interactions within the respiratory complex
Efficiency of proton translocation
Stability of the protein in the membrane environment
Assembly kinetics of the complex
The high conservation across strains indicates strong evolutionary pressure to maintain nuoK function, with variations potentially reflecting adaptations to specific ecological niches or metabolic requirements of different E. coli pathotypes .
The antigenic relationship between E. coli O9 and O104 serogroups has significant implications for research:
Serological Cross-Reactivity:
Studies have demonstrated that anti-O9 serum shows reactivity with O104 antigens at dilutions of 1:400, while anti-O104 serum reacts with O9 antigens at dilutions of 1:200 . This cross-reactivity indicates shared epitopes between these serogroups that may complicate:
Serological identification of strains
Epidemiological tracking
Vaccine development
Diagnostic test specificity
Evolutionary Significance:
The shared antigenic determinants suggest:
Common evolutionary origins
Horizontal gene transfer of O-antigen biosynthesis genes
Selection pressures maintaining similar surface structures
Potential functional advantages of these specific O-antigens
Research Implications:
This relationship necessitates:
Careful absorption studies when developing serotyping reagents
Use of multiple identification methods beyond serology
Consideration of cross-reactivity when interpreting experimental results
Molecular approaches to supplement serological identification
Epidemiological Relevance:
Given that O104:H4 gained significance during the 2011 European outbreak , understanding its relationship with O9 strains provides:
Insights into the emergence of virulent strains
Potential surveillance targets
Context for genetic recombination events
Framework for tracking strain evolution
The careful distinction between these serogroups requires absorption of antisera with heterologous antigens to ensure accurate identification in research settings .
Recombinant nuoK serves as a valuable tool for investigating bacterial energy metabolism through multiple approaches:
Reconstitution Studies:
Purified nuoK can be incorporated into proteoliposomes along with other Complex I subunits
This system allows measurement of:
Proton translocation efficiency
NADH oxidation rates
Response to inhibitors
Membrane potential generation
Structure-Function Investigations:
Site-directed mutagenesis of conserved residues enables:
Identification of residues essential for proton translocation
Understanding of electron transfer coupling mechanisms
Elucidation of quinone-binding interactions
Mapping of conformational changes during catalysis
Comparative Bioenergetics:
Expression of nuoK variants from different bacterial species permits:
Evolutionary analysis of respiratory mechanisms
Identification of species-specific adaptations
Correlation of sequence variations with metabolic efficiency
Insights into bacterial adaptation to different energy sources
Drug Development Applications:
As part of the respiratory chain, nuoK represents a potential antibiotic target:
Screening assays using recombinant protein can identify inhibitors
Structure-based drug design targeting nuoK-specific features
Development of species-selective respiratory inhibitors
Evaluation of resistance mechanisms
These applications contribute to our fundamental understanding of bacterial metabolism while offering potential translational benefits for antimicrobial development.
Investigating protein-protein interactions of nuoK requires specialized approaches due to its membrane-embedded nature:
In Vitro Methods:
Cross-linking Studies:
Chemical cross-linkers of varying lengths can capture interactions
Mass spectrometry analysis identifies interaction partners
Requires careful optimization of cross-linker concentration and reaction time
Should be performed in native membrane environments when possible
Co-purification Approaches:
Tandem affinity purification with tagged nuoK
Pull-down assays using immobilized nuoK as bait
Size exclusion chromatography to isolate intact complexes
Blue native PAGE to preserve native protein complexes
In Silico Predictions:
Molecular docking simulations
Coevolutionary analysis of sequence alignments
Protein-protein interaction interface prediction
Molecular dynamics simulations of complex formation
In Vivo Methods:
Two-hybrid Systems Modified for Membrane Proteins:
Split-ubiquitin yeast two-hybrid system
Bacterial adenylate cyclase two-hybrid system (BACTH)
Optimization required for membrane protein expression
In Vivo Cross-linking:
Photo-activatable amino acid incorporation
In vivo chemical cross-linking followed by purification
Proximity labeling approaches (BioID, APEX)
Validation Approaches:
Mutagenesis of predicted interface residues
Competition assays with peptide fragments
FRET/BRET analysis of tagged proteins
Functional assays measuring complex activity
These methodological approaches should be combined to build a comprehensive interactome map of nuoK within the respiratory complex and potentially with other cellular components.
To systematically analyze the impact of nuoK mutations on respiratory complex assembly and function, researchers should implement a multi-faceted approach:
Mutation Design Strategy:
Conservation-based Selection:
Identify residues conserved across species
Target charged residues in transmembrane regions
Focus on residues at predicted subunit interfaces
Consider known disease-associated mutations in homologs
Mutation Classifications:
Conservative (similar physicochemical properties)
Non-conservative (altered charge or hydrophobicity)
Deletions or insertions
Chimeric constructs with related proteins
Assembly Analysis:
Quantitative Techniques:
Blue native PAGE with densitometry
Size exclusion chromatography profiles
Analytical ultracentrifugation
Mass photometry of intact complexes
Localization Studies:
Immunofluorescence microscopy
Membrane fractionation efficiency
Protease accessibility assays
Green fluorescent protein fusion localization
Functional Assessment:
Activity Measurements:
NADH:ubiquinone oxidoreductase activity
Oxygen consumption rates
Proton pumping efficiency
Membrane potential generation
Inhibitor Sensitivity:
Altered IC50 values for known inhibitors
Resistance profiles
Competitive inhibition kinetics
Cross-resistance patterns
Structural Analysis:
Hydrogen-deuterium exchange mass spectrometry
Limited proteolysis accessibility
Thermal stability shifts
Cryo-EM structural analysis when feasible
Data Integration Framework:
Correlation of structure, assembly, and function
Machine learning approaches to predict mutation impacts
Molecular dynamics simulations to rationalize experimental findings
Evolutionary analysis to interpret mutation significance
This comprehensive approach allows researchers to establish structure-function relationships at the residue level and understand the molecular basis of nuoK's role in the respiratory complex.
Rigorous experimental design for recombinant nuoK research requires implementation of appropriate controls:
Expression Controls:
Negative Controls:
Empty vector transformants
Inactive mutant versions (e.g., key residue mutations)
Non-induced cultures for inducible systems
Host cells without expression vector
Positive Controls:
Well-characterized membrane protein with similar properties
Previously validated nuoK preparation
Commercial NADH dehydrogenase (for activity comparisons)
Intact bacterial membranes with native complex
Purification Controls:
Control protein subjected to identical purification procedure
Deliberately denatured samples to establish baseline
Detergent-only samples to assess micelle effects
Time-course stability samples to monitor degradation
Activity Assay Controls:
Enzyme-free reaction mixtures
Heat-inactivated enzyme preparations
Known inhibitor treatments
Substrate analogs incapable of reaction
Specificity Controls:
Closely related NADH dehydrogenase subunits
Cross-species nuoK homologs
Deliberately misfolded protein preparations
Competitive inhibition with excess substrate
Technical Validation:
Multiple independent protein preparations
Different expression batches
Alternative detection methods
Randomized sample analysis order
Implementation of these controls ensures experimental rigor and facilitates reliable interpretation of results, particularly important when working with membrane proteins that present unique experimental challenges.
Validating the functionality of purified recombinant nuoK requires multiple complementary approaches:
Structural Integrity Assessment:
Circular dichroism spectroscopy to confirm secondary structure
Tryptophan fluorescence emission spectra
Size exclusion chromatography profiles
Thermal stability analysis
Biochemical Activity Assays:
Direct NADH Oxidation Measurement:
Spectrophotometric monitoring at 340 nm
Coupling with artificial electron acceptors
Competition with known inhibitors
Determination of kinetic parameters (Km, Vmax)
Proton Translocation Assays:
pH-sensitive fluorescent probes in proteoliposomes
Ion-selective electrode measurements
Membrane potential generation using voltage-sensitive dyes
Proton/electron stoichiometry determination
Integration Capacity:
Ability to associate with other complex I subunits
Reconstitution into artificial membrane systems
Complementation of nuoK-deficient bacterial strains
Co-purification with known interaction partners
Comparative Analysis:
Parallel testing with native complex
Comparison to related model systems
Benchmarking against published activity values
Activity ratios with different substrates/conditions
Stability Assessment:
Activity retention after storage
Resistance to multiple freeze-thaw cycles
Thermal inactivation profiles
Detergent compatibility testing
A comprehensive validation approach combining these methods provides confidence in the functional integrity of the purified recombinant protein and establishes its suitability for downstream applications.
Membrane proteins like nuoK present unique research challenges that require specialized approaches:
Expression Challenges:
Toxicity to Host Cells:
Solution: Use tightly controlled expression systems
Implementation: C41/C43 E. coli strains designed for toxic membrane proteins
Application: Tunable promoters allowing moderated expression levels
Misfolding and Aggregation:
Solution: Optimize expression temperature and induction conditions
Implementation: 16-20°C expression with low inducer concentrations
Application: Co-expression with chaperones like DnaK/DnaJ/GrpE
Purification Challenges:
Detergent Selection:
Challenge: Maintaining native structure during solubilization
Solution: Systematic screening of detergent types and concentrations
Implementation: Mild detergents like DDM, LMNG, or GDN
Protein Stability:
Challenge: Rapid degradation during handling
Solution: Addition of stabilizing agents
Implementation: Glycerol, specific lipids, and cholesterol hemisuccinate
Functional Analysis Challenges:
Artificial Environment Effects:
Challenge: Detergent micelles differ from native membrane
Solution: Reconstitution into lipid nanodiscs or proteoliposomes
Implementation: Matching lipid composition to native environment
Complex Assembly:
Challenge: Individual subunit may lack activity
Solution: Co-expression or reconstitution strategies
Implementation: Polycistronic constructs for coordinated expression
Structural Analysis Challenges:
Conformational Heterogeneity:
Challenge: Multiple conformational states
Solution: Conformation-stabilizing ligands or mutations
Implementation: Nanobodies or designed binding proteins
Crystallization Difficulties:
Challenge: Detergent interferes with crystal contacts
Solution: Alternative structural techniques
Implementation: Cryo-EM, NMR for smaller constructs
These specialized approaches enable successful study of challenging membrane proteins like nuoK, allowing researchers to overcome the inherent difficulties associated with these important biological components.
The study of nuoK from E. coli O9:H4 provides valuable insights into bacterial pathogenicity through several mechanisms:
Energy Metabolism and Virulence Connection:
Efficient energy generation via respiratory complexes supports:
Rapid growth during infection
Adaptation to nutrient-limited host environments
Persistence under stress conditions
Biofilm formation capability
Serotype-Specific Factors:
E. coli O9:H4 belongs to a group with significant pathogenic potential:
Host-Pathogen Interaction Insights:
Respiratory adaptation during infection:
Oxygen availability varies across infection sites
NADH-quinone oxidoreductase function critical under microaerobic conditions
Different efficiency of energy generation may contribute to tissue tropism
Metabolic adaptations influence competitive fitness in host
Therapeutic Target Potential:
Research on nuoK contributes to:
Identification of respiratory chain vulnerabilities
Development of serotype-specific inhibitors
Understanding of resistance mechanisms
Novel antimicrobial strategies targeting energy metabolism
The molecular characterization of nuoK in E. coli O9:H4 thus bridges fundamental biochemistry with pathogenesis research, offering insights into how basic cellular functions contribute to virulence and potential approaches for therapeutic intervention.
Recent technological advances have revolutionized membrane protein research, offering new opportunities for studying proteins like nuoK:
Structural Biology Breakthroughs:
Cryo-Electron Microscopy Advances:
Direct electron detectors enabling atomic resolution
Classification algorithms for conformational heterogeneity
Sample preparation innovations reducing preferred orientation
Application to smaller membrane proteins previously inaccessible
Innovative Crystallization Approaches:
Lipidic cubic phase crystallization
Crystal-free electron diffraction (MicroED)
XFEL-based serial crystallography
Antibody-mediated crystallization
Membrane Mimetic Systems:
Nanodisc Technology:
MSP-based nanodiscs with controlled size
Polymer-based nanodiscs (SMALPs, DIBMA)
Native nanodiscs preserving endogenous lipid environments
High-density lipoprotein particles as membrane mimetics
Advanced Liposome Technology:
Controlled composition proteoliposomes
Giant unilamellar vesicles for single-particle studies
Asymmetric bilayers mimicking biological membranes
Tethered vesicle systems for long-term stability
Cutting-Edge Spectroscopic Methods:
Single-Molecule Techniques:
FRET-based conformational dynamics studies
High-speed AFM for real-time visualization
Patch-clamp fluorometry combining functional and structural data
Single-molecule force spectroscopy
Advanced EPR Applications:
DEER/PELDOR for distance measurements
ENDOR for interaction characterization
High-field EPR for improved resolution
Spin-labeling strategies for membrane proteins
Computational Advances:
Molecular Dynamics Capabilities:
Specialized force fields for membrane environments
Enhanced sampling techniques for rare events
Microsecond to millisecond simulations
Quantum mechanics/molecular mechanics hybrid approaches
AI/ML Applications:
AlphaFold2 and RoseTTAFold for structure prediction
Deep learning for functional annotation
Automated image processing in cryo-EM
Virtual screening for ligand discovery
These technological advances collectively enhance our ability to study challenging membrane proteins like nuoK, providing unprecedented insights into their structure, function, and dynamics in near-native environments.
The study of nuoK and related respiratory proteins presents several promising future research directions:
Systems Biology Integration:
Multi-omics approaches linking respiratory function to global metabolic networks
Quantitative models of respiratory chain dynamics under varying conditions
Integration of protein-level data with transcriptomics and metabolomics
Network analysis of respiratory complex assembly and regulation
Medical and Biotechnological Applications:
Development of novel antimicrobials targeting nuoK and related subunits
Engineering of respiratory complexes for improved bioenergetic efficiency
Creation of biosensors based on respiratory components
Design of minimal respiratory systems for synthetic biology applications
Advanced Structure-Function Investigations:
Time-resolved structural studies capturing conformational changes
Investigation of proton translocation mechanisms at atomic resolution
Mapping of quinone binding sites and electron transfer pathways
Characterization of supercomplexes involving NADH-quinone oxidoreductase
Comparative Biology Approaches:
Evolutionary analysis across diverse bacterial species
Adaptation of respiratory complexes to extreme environments
Host-pathogen co-evolution of respiratory systems
Cross-species functional complementation studies
Technological Development:
CRISPR-based high-throughput mutagenesis of respiratory complex genes
Development of novel membrane mimetics for functional studies
Advanced imaging techniques for visualizing complexes in native membranes
Computational methods for predicting assembly pathways and dynamics
These research directions promise to expand our understanding of bacterial respiratory complexes, with implications for fundamental science, antimicrobial development, and biotechnological applications.
Research on E. coli nuoK provides valuable insights for understanding mitochondrial complex I disorders through evolutionary and functional parallels:
Structural Conservation Relevance:
Bacterial nuoK is homologous to the mitochondrial ND4L subunit
Both proteins share:
Key transmembrane topology features
Functionally critical conserved residues
Roles in proton translocation
Positions within the membrane arm of complex I
Disease Mutation Modeling:
Bacterial systems offer advantages for studying disease-associated mutations:
Faster generation time and simpler genetic manipulation
Ability to isolate effects in a less complex system
Higher protein yields for biochemical and structural studies
Complementation assays to validate mutation impacts
Mechanistic Insights:
E. coli studies contribute to understanding:
Fundamental proton pumping mechanisms
Assembly pathways conserved between bacteria and mitochondria
Electron transfer coupling to proton translocation
Inhibitor binding sites relevant to drug development
Translational Applications:
Bacterial research facilitates:
High-throughput screening for therapeutic compounds
Validation of computational predictions about mutation effects
Development of assays applicable to clinical samples
Understanding of secondary compensatory mechanisms